INICIO

Continuation of the Revista Mexicana de Cardiología

  • Home
  • Instructions for authors
    • Instructions for authors
    • Regulations for the publication of supplements
  • Publish
  • Directory
  • Publications
    • Current issue                  
    • All issues
  • About Us
    • About the Journal            
    • Publisher Policies
    • Previous Titles
    • Editorial Management
  • Contact





2025, Number 1

Cardiovasc Metab Sci 2025; 36 (1)

Prophylactic use of intravascular balloon occlusion in elective general non-cardiac surgery. Systematic review and meta-analysis of the literature

Caicedo-Moncada, Brainerd Lenin; Beltrán-Torres, Felipe Andrés; Mendez-Ordoñez, Erika Marcela

ABSTRACT

Introduction: the use of endovascular occlusion balloon in elective non-cardiac surgery has emerged as an effective strategy to prevent intraoperative bleeding, a significant complication that can impact both surgical outcomes and patient recovery. This device, which selectively occludes large blood vessels, allows for precise control of blood flow, thereby minimizing the risk of hemorrhage and improving visibility in critical surgical areas. Material and methods: a search was performed across three major databases (PubMed, Ovid, and Embase), in addition to Google Scholar as a source of gray literature and the National Institute of Health (NIH) as a national database, covering the period from 2014 to 2024. Results: this systematic review included 17 articles; two showed a moderate risk of bias, while the others demonstrated good quality and low risk of bias. A total of 3,379 patients were analyzed, 95.3% women. The primary indication for the use of endovascular occlusion balloons was surgical procedures related to abnormal placentation in 67.5% of cases, with an average blood loss of 1,256 mL (SD: 699.9). The application of the balloon resulted in a significant reduction in blood loss of 856 mL (OR −3.43; 95% CI −6.22 to −0.63), with no significant differences observed in age, gender, or surgical duration. Conclusion: the use of intravascular balloon occlusion in elective non-cardiac general surgical procedures with a high risk of hemorrhage demonstrates effectiveness in reducing intraoperative blood loss. The most frequently observed complications include transient arterial thrombosis and localized issues at the puncture site. While various clinical scenarios for its application have been described, the strongest evidence supports its use in obstetric procedures, particularly those related to abnormal placentation.
  FULL TEXT PDF  

Keywords

intravascular balloon occlusion hemorrhage elective surgery




  • Send manuscript
  • Instructions for authors
  • Recent
  • TOP 5
  • Observational Registry for Cardiac Ablation in Atrial Fibrillation in Mexico...
    2025, Vol.36, Núm. 1
  • Inflammation indices in chronic stable coronary artery disease
    2025, Vol.36, Núm. 1
  • Statement from the Presidency of ANCAM and its Editorial Committee
    2025, Vol.36, Núm. 1
  • Coronary artery to right pulmonary artery fistula in an adolescent
    2025, Vol.36, Núm. 1
  • The MACARENHA connection: a holistic approach to understand and fight the...
    2025, Vol.36, Núm. 1
  • Effectiveness and safety of amphepramone in a slow release as part of the...
    2007, Vol.18, Núm. 1
  • Etiology and pathophysiology of type 2 diabetes mellitus
    2011, Vol.22, Núm. 1
  • Long QT syndrome secondary to drug interaction between hydroxychloroquine and...
    2018, Vol.29, Núm. 2
  • Early repolarization. Normal or dangerous?
    2011, Vol.22, Núm. 3
  • Official Mexican Standard NOM-030-SSA2-2009. For the prevention, detection,...
    2011, Vol.22, Núm. 3

Cardiovascular and Metabolic Science Vol. 36, Num. 1, Enero-Marzo 2025. Es una publicación trimestral editada por la Asociación Nacional de Cardiólogos de México. Magdalena 135. Col. Del Valle. Del. Benito Juárez. Ciudad de México, México. C.P. 03103. Tel. 5556368002 https://www.cardiovascularandmetabolicscience.org.mx/ ancam@ancam.org.mx https://www.medigraphic.com/cms/ E-mail addresses: revmexcardiol@gmail.com Editor responsable. Dr. Eduardo Meaney Mendiolea. Reserva de Derechos al Uso Exclusivo Nº 04-2019-061316491900-203. ISSN: 2683-2828 versión impresa y 2954-3835 versión electrónica. Ambos otorgados por el Instituto Nacional del Derecho de Autor. Responsable de la última actualización de este número, Departamento de Internet, Graphimedic, S.A. de C.V., Ing. Luis Rosales Jiménez, Coquimbo 936, Col. Lindavista, Delegación Gustavo A. Madero, C.P. 07300, Ciudad de México, México. Fecha de última modificación, 04 de abril de 2024.

 

2025     |     https://www.cardiovascularandmetabolicscience.org.mx/